German-based radiopharmaceutical biotech company ITM Isotope Technologies Munich and Canadian Nuclear Laboratories are launching a new joint venture company for the industrial-scale production of actinium-225, which is used in targeted alpha therapies to fight cancer. The new company is being called Actineer.
Canada clears Darlington to produce Lu-177 and Y-90
The Canadian Nuclear Safety Commission has amended Ontario Power Generation’s power reactor operating license for Darlington nuclear power plant to authorize the production of the medical...
TVA files for Clinch River SMR construction permit
The Tennessee Valley Authority announced yesterday that it has submitted a construction permit application to the Nuclear Regulatory Commission for the construction of a GE Vernova Hitachi...
Nuclear moratoriums crumble around the world
The recent surge in positive sentiment about nuclear as the most viable answer to global energy needs and decarbonization goals has found governments around the world taking steps to reverse...
ANS holds Educator Training webinar on nuclear waste
A recent American Nuclear Society webinar tackled misconceptions about nuclear waste. Christopher Perfetti, an associate professor of nuclear engineering at the University of New Mexico,...
NWMO chooses vendors for Canadian repository
Canada’s Nuclear Waste Management Organization has selected five companies it is to work with to design and plan the organization’s proposed deep geologic repository for spent nuclear...
Oak Ridge’s Isotek dramatically increases world supply of Th-229
Workers with Oak Ridge Office of Environmental Management contractor Isotek have surpassed a significant milestone in the supply of medical radioisotopes, extracting more than 15 grams of rare...
OPG gets final permission to construct first North American SMR
Ontario Power Generation GE Vernova Hitachi Nuclear Energy announced May 8 that Ontario authorities have approved construction plans for the first of four BWRX-300 small modular reactors at...
SHINE to acquire Lantheus’s SPECT business line
SHINE Technologies, a fusion company building what is set to be the world’s largest medical isotope production facility at its Wisconsin campus, announced that it has agreed to acquire the...
Nuclear's future discussed at MURR expansion
ANS Executive Director/CEO Craig Piercy recently spoke on nuclear power’s potential for answering today’s energy demands as part of the Distinguished Lecture Series at the University of...
A good narrative for nuclear power
During an interview for Kitco News at the 2025 Prospectors & Developers Association of Canada (PDAC) Convention, held in Toronto in early March, the chief executive of British...